Purchases and Sales Made in Q1 2025 in Janux Therapeutics, Inc. (JANX)
This table provides information about the institutional ownership of Janux Therapeutics, Inc. (JANX) during Q1 2025. The information is specifically focused on institutions that hold shares of Janux Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Artia Global Partners LP
Miami, FL |
SELL
|
- |
-125K- 76.62% |
$3.37M - $7.22M
|
38.1K
$1.06M
|
|
|
May 15, 2025
Q1 2025
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-186K- 5.29% |
$5.02M - $10.8M
|
3.33M
$92.4M
|
|
|
May 15, 2025
Q1 2025
|
Barclays PLC
London, X0 |
SELL
|
- |
-196K- 74.33% |
$5.3M - $11.3M
|
67.8K
$1.88M
|
|
|
May 15, 2025
Q1 2025
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-245K- 39.38% |
$6.61M - $14.1M
|
377K
$10.5M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-395K- 21.33% |
$10.7M - $22.8M
|
1.46M
$40.4M
|
|
|
May 15, 2025
Q1 2025
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-484K- 65.22% |
$13.1M - $28M
|
258K
$7.16M
|
|
|
May 13, 2025
Q1 2025
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-600K- 47.32% |
$16.2M - $34.7M
|
668K
$18.5M
|
|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-654K- 48.07% |
$17.7M - $37.8M
|
707K
$19.6M
|